Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes
暂无分享,去创建一个
Heather L. Mulder | Michael C. Rusch | Michael N. Edmonson | J. Downing | M. Edmonson | M. Fornerod | Jing Ma | D. Liang | L. Shih | Guangchun Song | J. Easton | D. Reinhardt | A. Yeoh | M. Rusch | H. Mulder | Jinghui Zhang | M. Walsh | F. Locatelli | Yongjin Li | S. Halene | P. Gupta | M. Pigazzi | M. V. D. van den Heuvel-Eibrink | Jinjun Cheng | D. Krause | A. Obulkasim | M. Zimmermann | C. Zwaan | T. Gruber | K. Reinhardt | J. Dang | L. Verboon | Joshua Yew Suang Lim | Jasmijn D. E. de Rooij | C. Koss | Cristyn Branstetter | Michael P. Walsh | Michael P Walsh | M. Zimmermann | Cary Koss
[1] Salam A. Assi,et al. UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO , 2016, Leukemia.
[2] S. Raimondi,et al. Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study. , 2015, Blood.
[3] D. Reinhardt,et al. Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial , 2015, Annals of Hematology.
[4] Cheng Cheng,et al. The landscape of somatic mutations in Infant MLL rearranged acute lymphoblastic leukemias , 2015, Nature Genetics.
[5] S. Emmrich,et al. LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia , 2014, Molecular Cancer.
[6] S. Miyano,et al. The landscape of somatic mutations in Down syndrome–related myeloid disorders , 2013, Nature Genetics.
[7] David G Hendrickson,et al. Differential analysis of gene regulation at transcript resolution with RNA-seq , 2012, Nature Biotechnology.
[8] R. Pieters,et al. NUP98/JARID1A Is a New Recurrent Genetic Abnormality in Pediatric Acute Megakaryoblastic Leukemia with a Distinct HOX -Gene Expression Pattern , 2012 .
[9] Heather L. Mulder,et al. An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. , 2012, Cancer cell.
[10] D. Reinhardt,et al. GATA1-Mutations-assoziierte Leukämien bei Kindern mit Trisomie 21-Mosaik , 2012, Klinische Pädiatrie.
[11] Christopher A. Miller,et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.
[12] J. Crispino,et al. Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome. , 2012, The Journal of clinical investigation.
[13] Kiran C. Bobba,et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.
[14] Cole Trapnell,et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.
[15] F. Bessho,et al. Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy , 2010, International journal of hematology.
[16] S. Orkin,et al. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. , 2010, Genes & development.
[17] Davis J. McCarthy,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[18] J. Downing,et al. Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia , 2009, Proceedings of the National Academy of Sciences.
[19] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[20] N. Sebire,et al. ERG is a megakaryocytic oncogene. , 2009, Cancer research.
[21] Cheng Cheng,et al. Reference alignment of SNP microarray signals for copy number analysis of tumors , 2009, Bioinform..
[22] Joshua M. Korn,et al. Integrated detection and population-genetic analysis of SNPs and copy number variation , 2008, Nature Genetics.
[23] Elizabeth A. Kruse,et al. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells , 2008, Nature Immunology.
[24] T. Alonzo,et al. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: Report from the Children's Oncology Group , 2007, Pediatric blood & cancer.
[25] E. Passegué,et al. Evidence that the Pim1 kinase gene is a direct target of HOXA9. , 2007, Blood.
[26] Christopher B. Miller,et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.
[27] D. Reinhardt,et al. AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity , 2005, Leukemia.
[28] M. Wigler,et al. Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.
[29] L. Feuk,et al. Detection of large-scale variation in the human genome , 2004, Nature Genetics.
[30] Cheng Li,et al. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data , 2004, Bioinform..
[31] M. Derynck,et al. The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells. , 2004, Blood.
[32] S. Jhanwar,et al. Chromosome 19 abnormalities are commonly seen in AML, M7. , 2002, Blood.
[33] M. Vignetti,et al. Acute megakaryoblastic leukemia: experience of GIMEMA trials , 2002, Leukemia.
[34] R. Berger,et al. Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH). , 2002, Blood.
[35] Dean Nizetic,et al. Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia , 2001, Nature Genetics.
[36] F. Behm,et al. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. , 2001, Blood.
[37] Nicole Dastugue,et al. Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[38] A. Kingsman,et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. , 1995, Nucleic acids research.
[39] V. Broudy,et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin , 1994, Nature.
[40] A. Baruchel,et al. Nonrandom t(1;22)(p12-p13;q13) in acute megakaryocytic malignant proliferation. , 1991, Cancer genetics and cytogenetics.
[41] D. Reinhardt,et al. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic]. , 2012, Klinische Padiatrie.
[42] Jelle J. Goeman,et al. A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..